Breadcrumb
10/11/22
The Evolution of Value Assessment in the US: Considerations and Controversies
Webinar recorded Oct. 4, 2022
Objectives – within the value assessment context, our expert panel will:
- Discuss the evolution of these frameworks in the US
- Explore payer perspectives and factors for decision making
- Elucidate considerations and controversies in applying value assessments to inform coverage and reimbursement
- Identify emerging trends that will impact the landscape
Description
The impact of value assessment frameworks on formulary decision making continues to create debate and influence manufacturers’ evidence-gathering strategies. Join our expert panel as they explore the evolving landscape of these frameworks, uncover payer perspectives, discuss questions and considerations regarding the real-world application, and forecast emerging trends that will shape value assessment in the future.
Speakers
Moderator:
- Joseph Washington, PharmD, MPH
Research Fellow, Health Outcomes and Market Access
AmerisourceBergen/Xcenda
Panelist:
- Kimberly Westrich, MA
Director, Value & Access Strategy
AmerisourceBergen/Xcenda - Jennifer Graff, PharmD
Senior Director, Professional Affairs
AMCP - Tasmina Hydery, PharmD, MBA, BCGP
Assistant Director, Digital Solutions
FormularyDecisions®